Results about: cancer therapy

P38MAM

New combination therapy for breast tumours, with selection marker

Key role identified for enzymes in DNA replication and sensitivity to chemotherapeutic drugs

Published in Science Advances, the study shows that the TLK1 and TLK2 enzymes are critical for ensuring the copying of DNA.

Loss of TLK1 and TLK2 results in extensive DNA damage during DNA replication and in cancer cell death.

Depletion of TLK1/2 enhances the effectiveness of some chemotherapeutic agents currently being tested in clinical trials

Exploring new frontiers in colorectal cancer research

ICREA research professor Eduard Batlle is featured in the “Meet Our Scientists” video entitled “Deconstructing colon cancer”.

The video presents IRB Barcelona's Colorectal Cancer Laboratory research, which is devoted to understanding the behaviour of colon tumours and propose new cures for patients.

CaixaImpulse funds an IRB Barcelona immunotherapy project for head and neck cancers

Gonzalo Fernández-Miranda, associate researcher at IRB Barcelona, leads this therapeutic project selected by CaixaImpulse to facilitate its development towards the market.